Product Description

KCTD7 Polyclonal Antibody

Sizes: 50μl, 100μl

Catalogue Numbers: BS65701-50, BS65701-100

Lead times: 1-2 weeks, if manufacturer has product in stock

Manufacturer/Ship Location: China

Background: Epilepsy affects about 0.5% of the world’s popμlation and has a large genetic component. Epilepsy resμlts from an electrical hyperexcitability in the central nervous system. Potassium channels are important regμlators of electrical signaling, determining the firing properties and responsiveness of a variety of neurons. Benign familial neonatal convμlsions (BFNC), an autosomal dominant epilepsy of infancy, has been shown to be caused by mutations in the KCNQ2 or the KCNQ3 potassium channel genes. KCNQ2 and KCNQ3 are voltage-gated potassium channel proteins with six putative transmembrane domains. Both proteins display a broad distribution within the brain, with expression patterns that largely overlap.

Category: Primary Antibody

Reactivity: Human, Mouse, Rat, Chicken, Dog, Pig, Cow, Horse, Rabbit, Sheep

Host: Rabbit

Applications: FCM

Alternate Names: BTB/POZ domain containing protein KCTD7, EPM3, FLJ32069, Potassium channel tetramerisation domain containing 7, KCTD7_HUMAN. 

Clonality: Polyclonal

Conjugate: Unconjugated

Modification: Unmodification

Immunogen: KLH conjugated synthetic peptide derived from human KCTD7:112-180/289

Dilution: Flow-Cyt=1ug/test

Purification: affinity purified by Protein A

Specificity: KCTD7 Polyclonal Antibody detects endogenous levels of KCTD7 protein.

Molecular Weight: 33kDa

Storage and Stability: Store at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze-thaw cycles.

SwissProt: Q96MP8

Product: 0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol.

Research Use Only